A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 73.00
-1.10 (-1.48%)
Oct 30, 2026, 1:23 PM CST
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.49 billion as of October 30, 2026. It is the 26,914th most valuable company in the world and the 1,493rd biggest in Taiwan. Its market cap has decreased by 14.86% in one year.
Market Cap
2.49B
Enterprise Value
2.18B
Revenue
887.93M
Global Rank
Country Rank
#1,493 Taiwan
PE Ratio
13.52
ChartMarket Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.49B, an increase of 63.25%. That is a compound annual growth rate of 13.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 2.49B | -15.85% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 78.73% |
| Dec 29, 2023 | 1.37B | -10.26% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.23B |
| Applied BioCode | 2.92B |
| Apex Biotechnology | 2.90B |
| Bonraybio | 2.70B |
| Wellell | 2.36B |
| Dynamic Medical Technologies | 2.18B |
| Medimaging Integrated Solution | 2.07B |
| OK Biotech | 2.07B |